Probiotic-Associated Aspiration Pneumonia Due to Lactobacillus rhamnosus
- 2014-08
- Journal of Clinical Microbiology 52(8)
- C. Doern
- Sean T. Nguyen
- F. Afolabi
- C. Burnham
- PubMed: 24899028
- DOI: 10.1128/JCM.01065-14
Abstract
Lactobacilli are low-virulence, commensal organisms of the gastrointestinal and genitourinary tracts and are commonly used as "probiotic supplements." Herein, we describe an episode of respiratory syncytial virus (RSV) bronchiolitis with bacterial superinfection secondary to administration of Lactobacillus rhamnosus in an 11-month-old female with trisomy 21.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lactobacillus rhamnosus LBV 96 | Reduced Incidence of Aspiration Pneumonia | Harmful | Moderate |
Lactobacillus rhamnosus LBV96 | Reduced Incidence of Aspiration Pneumonia | Harmful | Moderate |
Lactobacillus rhamnosus VPro 11 | Reduced Incidence of Aspiration Pneumonia | Harmful | Moderate |